SFINX-a drug-drug interaction database designed for clinical decision support systems

被引:119
作者
Bottiger, Ylva [5 ]
Laine, Kari [2 ,3 ,4 ]
Andersson, Marine L. [5 ]
Korhonen, Tuomas [2 ,3 ,4 ]
Molin, Bjorn [1 ]
Ovesjo, Marie-Louise [5 ]
Tirkkonen, Tuire [2 ,3 ,4 ]
Rane, Anders [5 ]
Gustafsson, Lars L. [1 ,5 ]
Eiermann, Birgit [1 ]
机构
[1] Stockholm Cty Council, Dept Drug Management & Informat, SE-11891 Stockholm, Sweden
[2] Medbase Ltd, Turku, Finland
[3] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland
[4] TYKSLAB, Clin Pharmacol Unit, Turku, Finland
[5] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, SE-14186 Stockholm, Sweden
关键词
Drug-drug interaction database; Clinical decision support system; Drug interactions; CARE; MANAGEMENT; KNOWLEDGE; CODEINE; ALERTS; POINT;
D O I
10.1007/s00228-008-0612-5
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Objective The aim was to develop a drug-drug interaction database (SFINX) to be integrated into decision support systems or to be used in website solutions for clinical evaluation of interactions. Methods Key elements such as substance properties and names, drug formulations, text structures and references were defined before development of the database. Standard operating procedures for literature searches, text writing rules and a classification system for clinical relevance and documentation level were determined. ATC codes, CAS numbers and country-specific codes for substances were identified and quality assured to ensure safe integration of SFINX into other data systems. Much effort was put into giving short and practical advice regarding clinically relevant drug-drug interactions. Results SFINX includes over 8,000 interaction pairs and is integrated into Swedish and Finnish computerised decision support systems. Over 31,000 physicians and pharmacists are receiving interaction alerts through SFINX. User feedback is collected for continuous improvement of the content. Conclusion SFINX is a potentially valuable tool delivering instant information on drug interactions during prescribing and dispensing.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 33 条
[1]
General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software [J].
Ahearn, MD ;
Kerr, SJ .
MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (01) :34-37
[2]
[Anonymous], 2008, Stockley's Drug Interactions
[3]
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature [J].
Bergk, V ;
Haefeli, WE ;
Gasse, C ;
Brenner, H ;
Martin-Facklam, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) :327-335
[4]
Exposure to potential drug interactions in primary health care [J].
Bjerrum, L ;
Andersen, M ;
Petersen, G ;
Kragstrup, J .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (03) :153-158
[5]
Janus computerised prescribing system provides pharmacological knowledge at point of care - design, development and proof of concept [J].
Eliasson, M ;
Bastholm, P ;
Forsberg, P ;
Henriksson, K ;
Jacobson, L ;
Nilsson, A ;
Gustafsson, LL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (04) :251-258
[6]
*EMEA, 1998, CPMPICH29195 EMEA
[7]
*EMEA, 2008, EUR PUBL ASS REP EPA
[8]
Food and Drug Administration US Department of Health and Human Services, 2006, GUID IND DRUG INT ST
[9]
Effects of computerized clinical decision support systems on practitioner performance and patient outcomes - A systematic review [J].
Garg, AX ;
Adhikari, NKJ ;
McDonald, H ;
Rosas-Arellano, MP ;
Devereaux, PJ ;
Beyene, J ;
Sam, J ;
Haynes, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (10) :1223-1238
[10]
Grizzle AJ, 2007, AM J MANAG CARE, V13, P573